Norstella

Norstella introduces NorstellaLinQ: https://ow.ly/nqga50TGawG. It's biopharma’s first fully integrated data asset combining RWD—open and closed claims, lab results and EMR—with Norstella’s proprietary forecasting, clinical, regulatory, payer, coverage and commercial intelligence data. Get closer to the patient than ever before. Learn more about NorstellaLinQ at the link in this post.

Pharmaceutical Companies: Here are three key trends to watch in the urology channel and ways you can respond: https://ow.ly/3Soj50RvcCP #Urology #Pharma #PharmaCompanies #PharmaceuticalCompanies

Unlock unparalleled insights from industry leaders and stay at the forefront of market access developments. Explore top-tier thought leadership from MMIT’s experts. Gain invaluable perspectives to propel your success. Click now!

eBook Download: Despite facing talent shortages, supply chain disruptions and data challenges, the pharma industry persevered, driven by an unwavering commitment to innovation and patient care. https://ow.ly/qzZU50UBW54 As 2025 kicks off, we reflect on a year filled with triumphs and trials and eagerly anticipate the exciting ventures ahead. We have pinpointed five key areas that will shape the drug development landscape in the coming year: - Advanced Therapy Development - Artificial Intelligence - Patient Centricity & Market Access - Leveraging Data - Strategic Partnerships Dive into our latest eBook to explore insights from Norstella experts and industry leaders, highlighting the most significant opportunities for pharma in 2025. #Pharma #PharmaIndustry #CGTs #ADCs #RWD #DrugDevelopment

What's the current outlook for South Korea in pharma? Read our Spotlight on South Korea: Innovation, Clinical Trials, and Market Trends Shaping 2025 blog post to find out: https://ow.ly/Z1cv50V8GTx South Korea is a leading biopharma innovation hub, ranking third in new drug discoveries worldwide. With Seoul as the top global clinical trial city and AI-driven drug development surging, what's next for 2025? Despite a global decline in clinical trials, South Korea saw a 9% increase in 2023, driven by substantial R&D investment. Digital health and oncology continue to grow, with advancements in AI-powered drug pipelines, digital therapeutics, and antibody-drug conjugates. Izabela Chmielewska and Jung-Won Shin explore the latest trends, approvals, and challenges shaping South Korea's biopharma sector. Read more at the link in this post! #Norstella #FollowNorstella #Pipeline2Patient

Infographic Download: Learn about the biggest hurdles and innovations in rare disease drug development by downloading our infographic: https://ow.ly/6gNL50V8x9j More than 395 million people worldwide are affected by rare diseases, yet only 5% have an FDA-approved treatment. The road from pipeline to patient is filled with challenges — from small patient populations to complex regulatory pathways — but change is happening. This infographic explores the biggest hurdles in rare disease drug development and the innovations reshaping the landscape. It examines how AI, data-sharing, and patient-driven research are transforming drug discovery, how new clinical trial models are improving patient recruitment and retention, and how regulatory collaboration is accelerating approvals. Discover how technology, strategy, and patient advocacy are driving progress. Download the infographic now at the link in this post. #Norstella #Pipeline2Patient

Infographic Download: https://ow.ly/6gNL50V8x9j Today, February 28, is Rare Disease Day, a global event dedicated to raising awareness and support for people living with rare diseases. Learn about the biggest hurdles and innovations in rare disease drug development by downloading our infographic. More than 395 million people worldwide are affected by rare diseases, yet only 5% have an FDA-approved treatment. The road from pipeline to patient is filled with challenges — from small patient populations to complex regulatory pathways — but change is happening. This infographic explores the biggest hurdles in rare disease drug development and the innovations reshaping the landscape. It examines how AI, data-sharing, and patient-driven research are transforming drug discovery, how new clinical trial models are improving patient recruitment and retention, and how regulatory collaboration is accelerating approvals. Discover how technology, strategy, and patient advocacy are driving progress. Download the infographic now at the link in this post. #Norstella #Pipeline2Patient #RareDiseaseDay

100,000 LinkedIn followers. Thank you for being part of our journey. At Norstella, our mission is to bring life-saving therapies to market quicker and help patients in need. Stay with us for more industry insights, impactful updates, and inspiring stories. Together, we're making a difference.

Explore expert articles from our top publications in the newest issue of our free newsletter: Citeline Editors' Picks. In this issue we are covering Rare Disease Day, the future of US life sciences, animal testing, and more!? ? Subscribe today for expert analysis on pharma, medtech, and consumer health.